Study on Immersive VR for Anxiety and Pain Management in EVLA Procedures
A study is evaluating the feasibility and safety of immersive VR as an adjunct to anesthesia during EVLA for varicose veins.
Phase III
Vascular / Chronic Venous Insufficiency
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
Pharma and device companies may need to consider integrating VR solutions into their treatment protocols for chronic venous insufficiency.
Why it matters
The study on immersive VR for managing anxiety and pain during EVLA procedures could redefine patient care standards in vascular treatments. If successful, it may prompt pharma and device companies to integrate VR technologies into their offerings, enhancing patient outcomes and satisfaction.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results for feasibility and safety outcomes, as well as any subsequent interest from device manufacturers in VR applications.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.